Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases.

Scalco, Rebeca; Oliveira, Luca C; Lai, Zhengfeng; Harvey, Danielle J; Abujamil, Lana; DeCarli, Charles; Jin, Lee-Way; Chuah, Chen-Nee; Dugger, Brittany N (2024). Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases. Acta neuropathologica communications, 12(1), p. 134. BioMed Central 10.1186/s40478-024-01827-7

Preview

Text s40478-024-01827-7.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (4MB) | Preview

Accurate and scalable quantification of amyloid-β (Aβ) pathology is crucial for deeper disease phenotyping and furthering research in Alzheimer Disease (AD). This multidisciplinary study addresses the current limitations on neuropathology by leveraging a machine learning (ML) pipeline to perform a granular quantification of Aβ deposits and assess their distribution in the temporal lobe. Utilizing 131 whole-slide-images from consecutive autopsied cases at the University of California Davis Alzheimer Disease Research Center, our objectives were threefold: (1) Validate an automatic workflow for Aβ deposit quantification in white matter (WM) and gray matter (GM); (2) define the distributions of different Aβ deposit types in GM and WM, and (3) investigate correlates of Aβ deposits with dementia status and the presence of mixed pathology. Our methodology highlights the robustness and efficacy of the ML pipeline, demonstrating proficiency akin to experts' evaluations. We provide comprehensive insights into the quantification and distribution of Aβ deposits in the temporal GM and WM revealing a progressive increase in tandem with the severity of established diagnostic criteria (NIA-AA). We also present correlations of Aβ load with clinical diagnosis as well as presence/absence of mixed pathology. This study introduces a reproducible workflow, showcasing the practical use of ML approaches in the field of neuropathology, and use of the output data for correlative analyses. Acknowledging limitations, such as potential biases in the ML model and current ML classifications, we propose avenues for future research to refine and expand the methodology. We hope to contribute to the broader landscape of neuropathology advancements, ML applications, and precision medicine, paving the way for deep phenotyping of AD brain cases and establishing a foundation for further advancements in neuropathological research.

Interest & Impact

Downloads

5 since deposited on 19 Aug 2024
5 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item